Global Prenatal DNA Sequencing Market 2018-2022

出生前DNAシークエンシングの世界市場2018-2022

◆タイトル:Global Prenatal DNA Sequencing Market 2018-2022
◆商品コード:IRTNTR21138
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2018年4月16日
◆ページ数:121
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:Healthcare and Life Sciences
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、出生前DNAシークエンシングの世界市場について調査・分析し、市場概要、市場環境、出生前DNAシークエンシング市場規模、用途別(遺伝性疾患、非遺伝性疾患)分析、市場動向、競争環境、主要地域別市場規模(アメリカ、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。
・エグゼクティブサマリー
・調査範囲・調査手法
・出生前DNAシークエンシングの世界市場概要
・出生前DNAシークエンシングの世界市場環境
・出生前DNAシークエンシングの世界市場動向
・出生前DNAシークエンシングの世界市場規模
・出生前DNAシークエンシングの世界市場:業界構造分析
・出生前DNAシークエンシングの世界市場:用途別(遺伝性疾患、非遺伝性疾患)
・出生前DNAシークエンシングの世界市場:地域別市場規模・分析
・出生前DNAシークエンシングのアメリカ市場規模・予測
・出生前DNAシークエンシングのヨーロッパ市場規模・予測
・出生前DNAシークエンシングのアジア市場規模・予測
・出生前DNAシークエンシングの主要国分析
・出生前DNAシークエンシングの世界市場:意思決定フレームワーク
・出生前DNAシークエンシングの世界市場:成長要因、課題
・出生前DNAシークエンシングの世界市場:競争環境
・出生前DNAシークエンシングの世界市場:関連企業情報(ベンダー分析)

About Prenatal DNA Sequencing

Prenatal DNA sequencing is the method of DNA sequencing where DNA isolated from the blood of pregnant women to reveal the full genetic code of a fetus. It is useful in detecting disorders such as Down syndrome, cystic fibrosis, thalassemia, and cancer.

Technavio’s analysts forecast the global prenatal DNA sequencing market to grow at a CAGR of 13.50% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the global prenatal DNA sequencing market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Prenatal DNA Sequencing Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Agilent Technologies
• BGI
• F. Hoffmann-La Roche
• Illumina
• Laboratory Corporation of America
• Natera

Market driver
• Increasing prevalence of cancer
• For a full, detailed list, view our report

Market challenge
• High cost of sequencing
• For a full, detailed list, view our report

Market trend
• Growing technological improvements in DNA sequencing
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: MARKET SEGMENTATION BY APPLICATION
• Segmentation by application
• Comparison by application
• Genetic diseases
• Non-genetic diseases
• Market opportunity by application
PART 08: CUSTOMER LANDSCAPE
PART 09: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas
• EMEA
• APAC
• Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 12: MARKET TRENDS
• Increasing number of research activities on human genomics
• Growing technological improvements in DNA sequencing
• Increasing M&A
PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Agilent Technologies
• BGI
• F. Hoffmann-La Roche
• Illumina
• Laboratory Corporation of America
• Natera
• Other prominent vendors
PART 15: APPENDIX
• List of abbreviations

Exhibit 01: Parent market
Exhibit 02: Global DNA sequencing market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global prenatal DNA sequencing market 2017-2022 ($ mn)
Exhibit 09: Global prenatal DNA sequencing market – Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2017
Exhibit 18: Market condition – Five forces 2022
Exhibit 19: Global prenatal DNA sequencing market by application – Market share 2017-2022 (%)
Exhibit 20: Comparison by application
Exhibit 21: Common types of genetic disorders
Exhibit 22: Global prenatal DNA sequencing market by genetic diseases – Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Global prenatal DNA sequencing market by genetic diseases – Year-over-year growth 2018-2022 (%)
Exhibit 24: Global prenatal DNA sequencing market by non-genetic diseases – Market size and forecast 2017-2022 ($ mn)
Exhibit 25: Global prenatal DNA sequencing market by non-genetic diseases – Year-over-year growth 2018-2022 (%)
Exhibit 26: Market opportunity by application
Exhibit 27: Customer landscape
Exhibit 28: Global – Market share by geography 2017-2022 (%)
Exhibit 29: Regional comparison
Exhibit 30: Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 31: Americas – Year-over-year growth 2018-2022 (%)
Exhibit 32: Top 3 countries in Americas
Exhibit 33: EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 34: EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 35: Top 3 countries in EMEA
Exhibit 36: APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 37: APAC – Year-over-year growth 2018-2022 (%)
Exhibit 38: Top 3 countries in APAC
Exhibit 39: Market opportunity
Exhibit 40: R&D funding for cancer 2013-2016 ($ millions)
Exhibit 41: Cost of sequencing per genome 2001-2015 ($)
Exhibit 42: Prominent M&A in DNA sequencing market 2007-2014
Exhibit 43: Vendor landscape
Exhibit 44: Landscape disruption
Exhibit 45: Vendors covered
Exhibit 46: Vendor classification
Exhibit 47: Market positioning of vendors
Exhibit 48: Agilent Technologies overview
Exhibit 49: Agilent Technologies – Business segments
Exhibit 50: Agilent Technologies – Organizational developments
Exhibit 51: Agilent Technologies – Geographic focus
Exhibit 52: Agilent Technologies – Segment focus
Exhibit 53: Agilent Technologies – Key offerings
Exhibit 54: BGI: Overview
Exhibit 55: BGI: Business segments
Exhibit 56: BGI: Organizational developments
Exhibit 57: BGI: Geographic focus
Exhibit 58: BGI: Segment focus
Exhibit 59: BGI: Key offerings
Exhibit 60: F. Hoffmann-La Roche: Overview
Exhibit 61: F. Hoffmann-La Roche: Business segments
Exhibit 62: F. Hoffmann-La Roche: Organizational developments
Exhibit 63: F. Hoffmann-La Roche: Geographic focus
Exhibit 64: F. Hoffmann-La Roche: Segment focus
Exhibit 65: F. Hoffmann-La Roche: Key offerings
Exhibit 66: Illumina: Overview
Exhibit 67: Illumina: Business segments
Exhibit 68: Illumina: Organizational developments
Exhibit 69: Illumina: Geographic focus
Exhibit 70: Illumina: Segment focus
Exhibit 71: Illumina: Key offerings
Exhibit 72: Laboratory Corporation of America overview
Exhibit 73: Laboratory Corporation of America – Business segments
Exhibit 74: Laboratory Corporation of America– Organizational developments
Exhibit 75: Laboratory Corporation of America – Geographic focus
Exhibit 76: Laboratory Corporation of America – Segment focus
Exhibit 77: Laboratory Corporation of America– Key offerings
Exhibit 78: Natera overview
Exhibit 79: Natera – Business segments
Exhibit 80: Natera– Organizational developments
Exhibit 81: Natera – Geographic focus
Exhibit 82: Natera – Segment focus
Exhibit 83: Natera – Key offerings



【掲載企業】

Agilent Technologies
BGI
F. Hoffmann-La Roche
Illumina
Laboratory Corporation of America
Natera
Other prominent vendors

★調査レポート[出生前DNAシークエンシングの世界市場2018-2022] (Global Prenatal DNA Sequencing Market 2018-2022 / IRTNTR21138)販売に関する免責事項
[出生前DNAシークエンシングの世界市場2018-2022] (Global Prenatal DNA Sequencing Market 2018-2022 / IRTNTR21138)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆